Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
4.450
+0.250 (5.95%)
At close: Jun 26, 2026, 4:00 PM EDT
4.342
-0.108 (-2.42%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Quoin Pharmaceuticals Stock Forecast
QNRX's stock price has decreased by -52.46% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Quoin Pharmaceuticals stock have an average target of 29.25, with a low estimate of 12 and a high estimate of 40. The average target predicts an increase of 557.30% from the current stock price of 4.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Quoin Pharmaceuticals stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| ThinkEquity | ThinkEquity | Buy Initiates $12 | Buy | Initiates | $12 | +169.66% | Jun 15, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $40 | Buy | Reiterates | $40 | +798.88% | May 8, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $35 | Buy | Reiterates | $35 | +686.52% | May 8, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $30 | Buy | Initiates | $30 | +574.16% | May 4, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.88
EPS Next Year
-2.91
from -6.88
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -5.85 | -1.92 | |
| Avg | -6.88 | -2.91 | |
| Low | -7.91 | -3.90 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.